SCHEMBL103697

SCHEMBL103697

S=[C]c1cccc2ccccc12

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 8/20 0.48
HSD17B10 Q99714 6/20 0.48
CYP1A2 P05177 6/20 0.48
HPGD P15428 4/20 0.48
CYP3A4 P08684 3/20 0.48
TDP1 Q9NUW8 2/20 0.48
ALOX15 P16050 2/20 0.48
ABCB11 O95342 1/20 0.48
NR3C1 P04150 1/20 0.48
ADRA2A P08913 1/20 0.48
ADORA3 P0DMS8 1/20 0.48
ADRA2C P18825 1/20 0.48
MAOA P21397 1/20 0.48
DRD1 P21728 1/20 0.48
SLC6A4 P31645 1/20 0.48
HTR2B P41595 1/20 0.48
CCR2 P41597 1/20 0.48
CA1 P00915 1/20 0.47
CA2 P00918 1/20 0.47
CYP2A6 P11509 3/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2854731 0.87 HPRT1 (0.58) ALDH1A1HSD17B10CYP1A2HPGDCYP3A4
SCHEMBL814962 0.84 HPRT1 (0.52) ALDH1A1HSD17B10CYP1A2HPGDCYP3A4
SCHEMBL1141298 0.84 HPRT1 (0.52) ALDH1A1HSD17B10CYP1A2HPGDCYP3A4
SCHEMBL10804459 0.84 HPRT1 (0.52) ALDH1A1HSD17B10CYP1A2HPGDCYP3A4
SCHEMBL29661843 0.79 CHAT (0.60) ALDH1A1HSD17B10CYP1A2HPGDCYP3A4
SCHEMBL2776015 0.79 CHAT (0.60) ALDH1A1HSD17B10CYP1A2HPGDCYP3A4
SCHEMBL6364668 0.77 CHAT (0.58) ALDH1A1HSD17B10CYP1A2HPGDCYP3A4
SCHEMBL1141388 0.76 CHAT (0.44) ALDH1A1HSD17B10CYP1A2HPGDCYP3A4
SCHEMBL1141385 0.76 CHAT (0.44) ALDH1A1HSD17B10CYP1A2HPGDCYP3A4
SCHEMBL10432886 0.76 CHAT (0.44) ALDH1A1HSD17B10CYP1A2HPGDCYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 298 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9711737-B2 Photoelectric conversion element and solid-state imaging device SONY CORPORATION (JP) 2017-07-18 US claimed
US-20160049595-A1 PHOTOELECTRIC CONVERSION ELEMENT AND SOLID-STATE IMAGING DEVICE SONY CORPORATION (JP) 2016-02-18 US claimed
US-9123901-B2 Photoelectric conversion element and solid-state imaging device SONY CORPORATION (JP) 2015-09-01 US claimed
US-8530662-B2 Pyridyltetrahydropyridines and pyridylpiperidines, and method of manufacturing them FUJIFILM FINECHEMICALS CO., LTD (JP) 2013-09-10 US claimed
US-20030087761-A1 Synergistic active compound combinations for controlling harmful plants AVENTIS CROPSCIENCE GMBH (DE) 2003-05-08 US claimed
US-20030004064-A1 Synergistic active compound combinations for controlling harmful plants AVENTIS CROPSCIENCE GMBH (DE) 2003-01-02 US claimed
WO-2002080680-A2 SYNERGISTIC ACTIVE COMBINATIONS FOR CONTROLLING HARMFUL PLANTS BAYER CROPSCIENCE GMBH (DE) 2002-10-17 WO claimed
WO-2002080679-A2 SYNERGISTIC ACTIVE COMBINATIONS FOR CONTROLLING HARMFUL PLANTS BAYER CROPSCIENCE GMBH (DE) 2002-10-17 WO claimed
US-5116960-A Fungicides BEECHAM GROUP P.L.C. (GB) 1992-05-26 US claimed
US-4579684-A Process for the manufacture of enol derivatives CIBA-GEIGY CORPORATION (US) 1986-04-01 US claimed
US-4550162-A Process for the manufacture of enol derivatives CIBA-GEIGY CORPORATION (US) 1985-10-29 US claimed
US-4293462-A Process for the manufacture of enol derivatives, and intermediates CIBA-GEIGY CORPORATION (US) 1981-10-06 US claimed
US-4110533-A PROCESS FOR THE MANUFACTURE OF ENOL DERIVATIVES CIBA-GEIGY CORPORATION (US) 1978-08-29 US claimed
US-12024579-B2 Curable liquid composition, particulate filler, and compound TOKYO OHKA KOGYO CO., LTD. (JP) 2024-07-02 US disclosed
WO-2023282014-A1 COMPOUND, PIGMENT, INK SHEET FOR THERMOSENSITIVE TRANSFER RECORDING 富士フイルム株式会社 2023-01-12 WO disclosed
CN-115336389-A Sealing agent, cured body, organic electroluminescent display device, and method for manufacturing organic electroluminescent display device 电化株式会社 2022-11-11 CN disclosed
EP-0016296-A1 Cephalosporin derivatives, process for their preparation, compositions containing them, and intermediates and their preparation CIBA-GEIGY AG (CH) 1980-10-01 EP disclosed
US-4147864-A Process for the manufacture of 7β-amino-3-cephem-3-ol-4 carboxylic acid compounds CIBA-GEIGY CORPORATION (US) 1979-04-03 US disclosed
US-4110533-A PROCESS FOR THE MANUFACTURE OF ENOL DERIVATIVES CIBA-GEIGY CORPORATION (US) 1978-08-29 US disclosed
US-4069324-A CEPHALOSPORIN ANTIBIOTICS CIBA-GEIGY CORPORATION (US) 1978-01-17 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030087761-A1 Synergistic active compound combinations for controlling harmful plants GSTA1, CASP9, BROX ALDH1A1 632/4885HSD17B10 1067/4885CYP1A2 130/4885
US-20030004064-A1 Synergistic active compound combinations for controlling harmful plants DDT, AADAT, MTX1 ALDH1A1 424/4885HSD17B10 1915/4885CYP1A2 82/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.